News
Bilateral, thin (<0.5 mm), grey-white, granular but continuous, mid-peripheral stromal corneal ring opacities were incidentally noted (Figs 1 and 2). The rings were 7–8 mm diameter and in cross ...
A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...
Over 300 people came out Thursday night for the annual “All That Jazz” Gala benefiting the Muscular Dystrophy Association. Since 2014, nearly $2 million dollars have been raised by MDA, which ...
WASHINGTON – Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the ...
Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy — the second fatality reported by the company in the past three months.
WASHINGTON — (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results